November 11, 2020
Argaman Recognized for Efforts Supporting the Development of Contact-Free Continuous Monitoring Devices Used By Global Healthcare Facilities
July 14, 2020
Discovery Point Retreat to Utilize Contact-Free Continuous Monitoring to Help Identify Patient Deterioration and Improve Client Sleep Cycles
May 27, 2020
Contact-free Continuous Monitoring among Leading Technologies Used in the Immersive Simulation Patient Room
May 20, 2020
Case Study Published in JAMDA and Presented at AMDA Highlights How Early Warning Indications Allow Staff to Identify Acute Changes of Condition For Preventative Action
May 13, 2020
WOBURN, Massachusetts, May 13, 2020 /PRNewswire/ — EarlySense, the global leader in contact-free, continuous monitoring solutions for the healthcare continuum, announced today that Matt Johnson, CEO of EarlySense, will present at the 13th Annual 2020 Healthcare Dealmakers Conference Digital Experience, taking place via webinar on Thursday May 14, 2020. Johnson will take part in a panel – The Pandemic Paradox – A Look at […]
May 12, 2020
Remote Monitoring Tracks Key Patient Changes, Enables Early Detection While Reducing Healthcare Worker Exposure
March 16, 2020
EarlySense Prepared to Implement Similar Solution in Hospitals and Skilled Nursing Facilities
February 24, 2020
EarlySense, the global leader in contact-free, continuous monitoring solutions for the healthcare continuum, today announced that Mr. John Dragovits has been appointed Senior Vice President of Strategic Partnerships. Dragovits will manage EarlySense's relationships with current and future business partners both domestically as well as in the international markets. These partnerships may include technology partners such is the case with Hillrom, healthcare organizations, technology developers and integrators, patient groups and more.
February 4, 2020
EarlySense, the global leader in contact-free, continuous monitoring solutions for the healthcare continuum, today announced a clinical validation study published in Anesthesiology comparing the performance of the EarlySense system and that of two wearable sensors and a patient worn monitor. The study determined that EarlySense's contact-free, bed-based system which measures heart rate and respiratory rate can be valuable in predicting clinical deterioration.
January 21, 2020
EarlySense was one of 10 Israeli companies selected by the UK-Israeli judging panel, out of almost 100 applicants. The companies will travel to London in February to meet and engage with the UK’s leading healthcare stakeholders in the fields of Big Pharma, healthcare provision, pharmacy retail, as well as local and national government.